Global Risk Assessment of Aflatoxins in Maize and Peanuts: Are Regulatory Standards Adequately Protective?

被引:85
作者
Wu, Felicia [1 ]
Stacy, Shaina L. [2 ]
Kensler, Thomas W. [3 ]
机构
[1] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA
[2] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
(36) aflatoxin; hepatocellular carcinoma; risk assessment; HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; PUBLIC-HEALTH; LIVER-CANCER; MOLECULAR ANALYSIS; DIETARY AFLATOXIN; YOUNG-CHILDREN; WEST-AFRICA; EXPOSURE; EPIDEMIOLOGY;
D O I
10.1093/toxsci/kft132
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The aflatoxins are a group of fungal metabolites that contaminate a variety of staple crops, including maize and peanuts, and cause an array of acute and chronic human health effects. Aflatoxin B1 in particular is a potent liver carcinogen, and hepatocellular carcinoma (HCC) risk is multiplicatively higher for individuals exposed to both aflatoxin and chronic infection with hepatitis B virus (HBV). In this work, we sought to answer the question: do current aflatoxin regulatory standards around the world adequately protect human health? Depending upon the level of protection desired, the answer to this question varies. Currently, most nations have a maximum tolerable level of total aflatoxins in maize and peanuts ranging from 4 to 20ng/g. If the level of protection desired is that aflatoxin exposures would not increase lifetime HCC risk by more than 1 in 100,000 cases in the population, then most current regulatory standards are not adequately protective even if enforced, especially in low-income countries where large amounts of maize and peanuts are consumed and HBV prevalence is high. At the protection level of 1 in 10,000 lifetime HCC cases in the population, however, almost all aflatoxin regulations worldwide are adequately protective, with the exception of several nations in Africa and Latin America.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 52 条
[1]   Morbidity in neonates of mothers who have ingested aflatoxins [J].
Abdulrazzaq, YM ;
Osman, N ;
Yousif, ZM ;
Trad, O .
ANNALS OF TROPICAL PAEDIATRICS, 2004, 24 (02) :145-151
[2]  
Alavian SM, 2012, INT J PREVENTIVE MED, V3, P770
[3]   Hepatitis B epidemiology in Asia, the Middle East and Africa [J].
André, F .
VACCINE, 2000, 18 :S20-S22
[4]  
[Anonymous], 1998, WHO FOOD ADDITIVES S
[5]  
[Anonymous], 2004, WORLDWIDE REGULATION
[6]   RISK ASSESSMENT FOR AFLATOXIN - AN EVALUATION BASED ON THE MULTISTAGE MODEL [J].
BOWERS, J ;
BROWN, B ;
SPRINGER, J ;
TOLLEFSON, L ;
LORENTZEN, R ;
HENRY, S .
RISK ANALYSIS, 1993, 13 (06) :637-642
[7]   Molecular analysis of hepatitis B virus in Bulgaria [J].
Ciccozzi, Massimo ;
Babakir-Mina, Muhammed ;
Lo Presti, Alessandra ;
Salpini, Romina ;
Cella, Eleonora ;
Gabanelli, Elena ;
Teoharov, Pavel ;
Kevorkyan, Ani ;
Perno, Carlo Federico ;
Zehender, Gianguglielmo ;
Ciotti, Marco .
JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (01) :49-54
[8]  
Cotty PJ, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P241, DOI 10.1079/9781845932657.0241
[9]   Separate and combined applications of nontoxigenic Aspergillus flavus and A-parasiticus for biocontrol of aflatoxin in peanuts [J].
Dorner, Joe W. ;
Horn, Bruce W. .
MYCOPATHOLOGIA, 2007, 163 (04) :215-223
[10]   MECHANISM OF AFLATOXIN CARCINOGENESIS [J].
EATON, DL ;
GALLAGHER, EP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :135-172